Download PDF
Thromb Haemost 1995; 74(01): 185-188
DOI: 10.1055/s-0038-1642674
Symposium
Tissue Factor
Schattauer GmbH Stuttgart

Tissue Factor Modulation of Factor Vlla Activity:Use in Measuring Trace Levels of Factor Vlla in Plasma

James H Morrissey
Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA
› Author Affiliations
Further Information

Publication History

Publication Date:
09 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Carson SD, Brozna JP. The role of tissue factor in the production of thrombin. Blood Coagul and Fibrinol 1993; 4: 281-292
    PubMedGoogle Scholar
  • 2 Nemerson Y, Esnouf MP. Activation of a proteolytic system by a membrane lipoprotein: Mechanism of action of tissue factor. Proc Natl Acad Sci USA 1973; 70: 310-310
    CrossrefPubMedGoogle Scholar
  • 3 Seligsohn U, Østerud B, Brown SF, Griffin JH, Rapaport SI. Activation of human factor VII in plasma and in purified systems: Roles of activated factor DC, kallikrein, and activated factor XII. J din Invest 1979; 64: 1056-1056
    PubMedGoogle Scholar
  • 4 Nemerson Y, Repke D. Tissue factor acceleratestheactivation of coagulation factor VII: The role of a bifunctional coagulation cofactor. Thromb Res 1985; 40: 351-351
    CrossrefPubMedGoogle Scholar
  • 5 Nakagaki T, Foster DC, Beikner KL, Kisiel W. Initiation of the extrinsic pathway of blood coagulation: Evidence for the tissue factor dependent autoactivation of human coagulation factor VII. Biochemistry 1991; 30: 10819-10824
    CrossrefPubMedGoogle Scholar
  • 6 Kondo S, Kisiel W. Regulation of factor VIIa in plasma: Evidence that antithrombin III is the sole plasma protease inhibitor of human factor VIIa. Thromb Res 1987; 46: 325-325
    CrossrefPubMedGoogle Scholar
  • 7 Seligsohn U, Kasper CK, Østerud B, Rapaport SI. Activated factor VII: Presence in factor DC concentrate and persistence in the circulation after infusion. Blood 1978; 53: 828-828
    PubMedGoogle Scholar
  • 8 Miller BC, Hultin MB, Jesty J. Altered factor VII activity in hemophilia. Blood 1985; 65: 845-845
    PubMedGoogle Scholar
  • 9 Nakagaki T, Foster DC, Beikner KI, Kisiel W. Initiation of the extrinsic pathway of blood coagulation: Evidence for the tissue factor dependent autoactivation of human coagulation factor VII. Biochemistry 1991; 30: 10819-10819
    CrossrefPubMedGoogle Scholar
  • 10 Neuenschwander PF, Morrissey JH. Deletion of the membrane-anchoring region of tissue factor abolishes autoactivation of factor VII, but not cofactor function: Analysis of a mutant with a selective deficiency in activity. J Biol Chem 1992; 267: 14477-14482
    PubMedGoogle Scholar
  • 11 Rapaport SI. Regulation of the tissue factor pathway. Ann NY Acad Sci 1991; 614: 151-151
    PubMedGoogle Scholar
  • 12 Morrissey JH, Fakhrai H, Edgington TS. Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade. Cell 1987; 50: 129-135
    CrossrefPubMedGoogle Scholar
  • 13 Spicer EK, Horton R, Bloem L, Bach R, Williams KR, Guha A, Kraus J, Lin T-C, Nemerson Y, Konigsberg WH. Isolation of cDNA clones coding for human tissue factor: Primary structure of the protein and cDNA. Proc Natl Acad Sci USA 1987; 84: 5148-5152
    CrossrefPubMedGoogle Scholar
  • 14 Scarpati EM, Wen D, Broze Jr GJ, Miletich JP, Flandermeyer RR, Siegel NR, Sadler JE. Human tissue factor: cDNA sequence and chromosome localization of the gene. Biochemistry 1987; 26: 5234-5238
    CrossrefPubMedGoogle Scholar
  • 15 Waxman E, Ross J BA, Laue TM, Guha A, Thiruvikraman SV, Lin TC, Konigsberg WH, Nemerson Y. Tissue factor and its extracellular soluble domain: The relationship between intermolecular association with factor VIIa and enzymatic activity of the complex. Biochemistry 1992; 31: 3998-4003
    CrossrefPubMedGoogle Scholar
  • 16 Waxman E, Laws WR, Laue TM, Nemerson Y, Ross JB A. Human factor VIIa and its complex with soluble tissue factor: Evaluation of asymmetry and conformational dynamics by ultracentrifugation and fluorescence anisotropy decay methods. Biochemistry 1993; 32: 3005-3012
    CrossrefPubMedGoogle Scholar
  • 17 Ruf W, Rehemtulla A, Morrissey JH, and Edgington TS. Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function. J Biol Chem 1991; 266: 2158-2166 correction in J Biol Chem 1991; 266 16256
    PubMedGoogle Scholar
  • 18 Shigematsu Y, Miyata T, Higashi S, Miki T, Sadler JE, Iwanaga S. Expression of human soluble tissue factor in yeast and enzymatic properties of its complex with factor VIIa. J Biol Chem 1992; 267: 21329-21337
    PubMedGoogle Scholar
  • 19 Paborsky LR, Caras IW, Fisher KL, Gorman C M. Lipid association, but not the transmembrane domain, is required fortissue factor activity. Substitution of the transmembrane domain with a phosphatidylinositol anchor J Biol Chem 1991; 266: 21911-21916
    PubMedGoogle Scholar
  • 20 Rezaie AR, Fiore MM, Neuenschwander PF, Esmon CT, Morrissey JH. Expression and purification of a soluble tissue factor fusion protein with an epitope for an unusual calcium-dependent antibody. Protein Express Purif 1992; 3: 453-460
    CrossrefPubMedGoogle Scholar
  • 21 Muller YA, Ultsch MH, Kelley RF, de Vos AM. Structure of the extracellular domain of human tissue factor: Location of the factor VIIa binding site. Biochemistry 1994; 33: 10864-10870
    CrossrefPubMedGoogle Scholar
  • 22 Harlos K, Martin DM A, O’Brien DP, Jones EY, Stuart DI, Polikarpov I, Miller A, Tuddenham EG D, Boys CW G. Crystal structure of the extracellular region of human tissue factor. Nature 1994; 370: 662-666
    CrossrefPubMedGoogle Scholar
  • 23 Bazan JF. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 1990; 87: 6934-6938
    CrossrefPubMedGoogle Scholar
  • 24 Gibbs CS, McCurdy SN, Leung LL K, Paborsky LR. Identification of the factor VIIa binding site on tissue factor by homologous loop swap and alanine scanning mutagenesis. Biochemistiy 1994; 33: 14003-14010
    PubMedGoogle Scholar
  • 25 Ruf W, Schullek JR, Stone MJ, Edgington TS. Mutational mapping of functional residues in tissue factor: Identification of factor VII recognition determinants in both structural modules of the predicted cytokine receptor homology domain. Biochemistry 1994; 33: 1565-1572
    CrossrefPubMedGoogle Scholar
  • 26 Schullek JR, Ruf W, Edgington TS. Key ligand interface residues in tissue factor contribute independently to factor VIIa binding. J Biol Chem 1994; 269: 19399-19403
    PubMedGoogle Scholar
  • 27 de Vos AM, Ultsch M, Kossiakoff AA. Human growth hormone and extracellular domain of its receptor: Crystal structure of the complex. Science 1992; 255: 306-312
    CrossrefPubMedGoogle Scholar
  • 28 Neuenschwander PF, Morrissey JH. Roles of the membrane-interactive regions of factor VIIa and tissue factor: The factor VIIa Gla domain is dispensable forbinding totissue factor but important for activation of factor X. J Biol Chem 1994; 269: 8007-8013
    PubMedGoogle Scholar
  • 29 Neuenschwander PF, Morrissey JH. Deletion of the membrane-anchoring region of tissue factor abolishes autoactivation of factor VII, but not cofactor function: Analysis of a mutant with a selective deficiency in activity. J Biol Chem 1992; 267: 14477-14482
    PubMedGoogle Scholar
  • 30 Fiore MM, Neuenschwander PF, Morrissey JH. The biochemical basis for the apparent defect of soluble mutant tissue factor in enhancing the proteolytic activities of factor VIIa. J Biol Chem 1994; 269: 143-149
    PubMedGoogle Scholar
  • 31 Paborsky LR, Caras IW, Fisher KL, Gorman CM. Lipid association, but not the transmembrane domain, is required fortissue factor activity. Substitution of the transmembrane domain with a phosphatidylinositol anchor J Biol Chem 1991; 266: 21911-21916
    PubMedGoogle Scholar
  • 32 Roy S, Hass PE, Bourell JH, Henzel WJ, Vehar GA. Lysine residues 165 and 166 are essential forthe cofactor function of tissue factor. J Biol Chem 1991; 266: 22063-22066
    PubMedGoogle Scholar
  • 33 Ruf W, Miles DJ, Rehemtulla A, Edgington TS. Cofactor residues lysine 165 and 166 are critical for protein substrate recognition by the tissue factor-factor VIIa protease complex. J Biol Chem 1992; 267: 6375-6381
    PubMedGoogle Scholar
  • 34 Ruf W, Miles DJ, Rehemtulla A, Edgington TS. Tissue factor residues 157-167 are required for efficient proteolytic activation of factor X and factor VII. J Biol Chem 1992; 267: 22206-22210
    PubMedGoogle Scholar
  • 35 Morrissey JH, Macik BG, Neuenschwander PF, Comp PC. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 81: 734-744 1993;
    PubMedGoogle Scholar
  • 36 Østerud B, Berrre A, Otnaess B-A, Bjoerklid E, Prydz H. Activation of the coagulation factor VII by tissue thromboplastin and calcium. Biochemistry 1972; 11: 2853-2853
    CrossrefPubMedGoogle Scholar
  • 37 Dalaker K, Prydz H. Coagulation factor VII in pregnancy. Br J Haematol 1984; 56: 233-233
    CrossrefPubMedGoogle Scholar
  • 38 Dalaker K, Hjeimann I, Prydz H. A novel form of factor VII in plasma from men at high risk for cardiovascular disease. Br J Haematol 1985; 61: 315-315
    CrossrefPubMedGoogle Scholar
  • 39 Dalaker K, Smith P, Amesen H, Prydz H. Factor VII activity in male survivors of acute myocardial infarction. Acta Med Scand 1987; 222: 111-111
    PubMedGoogle Scholar
  • 40 Hubbard AR, Parr LJ. Phospholipase C mediated inhibition of factor VII requires triglyceride-rich lipoproteins. Thromb Res 1991; 62: 335-344
    CrossrefPubMedGoogle Scholar
  • 41 Hayes TE, Pike J, Tracy RP. Factor VII assays. Arch Pathol Lab Med 1993; 117: 52-57
    PubMedGoogle Scholar
  • 42 Broze Jr GJ, Hickman S, Miletich JP. Monoclonal anti-human factor VII antibodies. J Clin Invest 1985; 76: 937-946
    CrossrefPubMedGoogle Scholar
  • 43 Takase T, Tuddenham E, Chand S, Goodall AH. Monoclonal antibodies to human factor VII: a one step immunoradiometric assay for VII. Ag. J Clin Pathol 1988; 41: 337-341
    PubMedGoogle Scholar
  • 44 Bom VJ J, van Tilburg NH, Krommenhoek-van EsC, Bertina RM. Immunoradiometric assays forhuman coagulation factor VII using polyclonal antibodies against the Ca(II)-dependent and Ca(II)-independent conformation. Thromb Haemostas 1986; 56: 343-348
    PubMedGoogle Scholar
  • 45 Kitchen S, Malia RG, Preston FE. A comparison of methods for the measurement of activated factor VII. Thromb Haemostas 1992; 68: 301-305
    PubMedGoogle Scholar
  • 46 Seligsohn U, Østerud B, Rapaport SI. Coupled amidolytic assay for factor VII: Its use with a clotting assay to determine the activity state of factor VII. Blood 1978; 52: 978-988
    PubMedGoogle Scholar
  • 47 Hemker HC, Muller AD, Gonggrup R. The estimation of activated human blood coagulation factor VII. J Mol Med 1976; 1: 127-134
    PubMedGoogle Scholar
  • 48 van Deijk WA, van Dam-Mieras MC E, Muller AD, Hemker HC. Evaluation of a coagulation assay determining the activity state of factor VII in plasma. Haemostasis 1983; 13: 192-197
    PubMedGoogle Scholar
  • 49 Kitchen S, Malia RG, Greaves M, Preston FE. A method forthe determination of activated factor VII using bovine and rabbit brain thromboplastins: Demonstration of increased levels in disseminated intravascularcoagulation. Thromb Res 1988; 50: 191-200
    CrossrefPubMedGoogle Scholar
  • 50 Poggio M, Tripodi A, Mariani G, Mannucci PM. Factor VII clotting assay: Influence of different thromboplastins and factor VH-deficient plasma. Thromb Haemostas 1991; 65: 160-164
    PubMedGoogle Scholar
  • 51 The ARIC Investigators: The atherosclerosis in communities (ARICH) study: Design and objectives. Am J Epidemiol 1989; 129: 687-702
    CrossrefPubMedGoogle Scholar
  • 52 Miller GJ, Stirling Y, Esnouf MP, Heinrich J, van de Loo J, Kienast J, Wu KK, Morrissey JH, Meade TW, Martin JC, Imeson JD, Cooper JA, Finch A. Factor VH-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: An international study. Thromb Haemost 1994; 71: 38-48
    Article in Thieme ConnectPubMedGoogle Scholar
  • 53 Hultin MB. Fibrinogen and factor VII as risk factors in vascular disease. Prog Haemost Thromb 1991; 10: 215-241
    PubMedGoogle Scholar
  • 54 Mann KG. Factor VII assays, plasma triglyceride levels, and cardiovascular disease risk. Arteriosclerosis 1989; 9: 783-784
    CrossrefPubMedGoogle Scholar
  • 55 Meade TW, Brozovic M, Chakrabarti RR, Haines AP, Imeson JD, Mellows S, Miller GJ, North WR S, Stirling Y, Thompson SG. Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study. Lancet 1986; 2: 533-537
    PubMedGoogle Scholar
  • 56 Balleisen L, Schulte H, Assmann G, Epping PH, van de Loo J. Coagulation factors and the progress of coronary heart disease. Lancet 1987; 2: 461-461 Letter
    PubMedGoogle Scholar
  • 57 Hoffman C, Shah A, Sodums M, Hultin MB. Factor VII activity state in coronary artery disease. J Lab Clin Med 1988; 111: 475-481
    PubMedGoogle Scholar
  • 58 Carvalho de Sousa J, Azevedo J, Soria C, Barros F, Ribeiro C, Parreira F, Caen JP. Factor VII hyperactivity in acute myocardial thrombosis: A relation to the coagulation activation. Thromb Res 1988; 51: 165-173
    CrossrefPubMedGoogle Scholar
  • 59 Cortellaro M, Boschetti C, Cofrancesco E, Zanussi C, Catalano M, de Gaetano G, Gabrielli L, Lombardi B, Specchia G, Tavazzi L, Tremoli E, della Volpe A, Polli E. and the PLAT Study Group The Plat Study: Hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients: Principal results. Arterioscler Thromb 1992; 12: 1063-1070
    CrossrefPubMedGoogle Scholar
  • 60 Ruddock V, Meade TW. Factor VII activity and ischaemic heart disease: Fatal and non-fatal events. QJMed 1994; 87: 403-406
    PubMedGoogle Scholar
  • 61 Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk. Arterioscler Thromb 1994; 14: 54-59
    CrossrefPubMedGoogle Scholar
  • 62 Wildgoose P, Nemerson Y, Hansen LL, Nielsen FE, Glazer S, Hedner U. Measurement of basal levels of factor VIIa in hemophilia A and B patients. Blood 1992; 80: 25-28
    PubMedGoogle Scholar
  • 63 Kario K, Miyata T, Sakata T, Matsuo T, Kato H. Fluorogenic assay of activated factor VII. Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese. Arterioscler Thromb 1994; 14: 265-274
    CrossrefPubMedGoogle Scholar
  • 64 Kario K, Sakata T, Matsuo T, Miyata T. Factor VII in non-insulin-dependent diabetic patients with microalbuminuria. Lancet 1993; 342: 1552-1552
    PubMedGoogle Scholar